{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:14Z","timestamp":1787070854266,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of this study was to construct a nomogram that will predict the overall survival (OS) of hepatocellular carcinoma (HCC) patients after transarterial chemoembolization (TACE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Imaging data, clinical characteristics, and serum des-\u03b3-carboxy prothrombin (DCP) levels of 93 HCC patients treated with TACE were collected. Lasso regression, random forest, and other methods were used to screen the OS-related variables and construct the Cox prognosis model. The model was visualized by nomogram, and the net benefit of the clinical decision was assessed by decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      It was found that DCP level after TACE was an important predictor of OS in HCC patients. The OS of the patients with lower serum DCP levels after TACE was significantly better than the group with higher levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003). The Cox prognostic model was constructed using four predictors including DCP reactivity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), modified Response Evaluation Criteria in Solid Tumors (mRECIST,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005), Child-Pugh class (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.018), and portal vein thrombosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.039). The C-index of the nomogram for OS of patients after TACE was 0.813. The clinical decision-making net benefits based on the nomogram were better than the decision-making based on the TNM stage system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>DCP reactivity and mRECIST are the key predictors of prognosis in HCC patients that received TACE as their initial treatment. The nomogram constructed with these two indicators as the core could predict the OS of HCC patients after TACE and help in clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_651_20","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T04:17:46Z","timestamp":1625804266000},"page":"707-714","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-\u03b3-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors"],"prefix":"10.4103","volume":"17","author":[{"given":"Su-Ming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu-Xing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Feng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Fang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20241021","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4103\/jcrt.JCRT_1030_19","article-title":"Transcatheter arterial chemoembolization combined with low-dose apatinib in the treatment of unresectable hepatocellular carcinoma in elderly patients: Efficacy and safety","volume":"16","author":"Liu","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"R2-15-20241021","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4103\/jcrt.JCRT_380_19","article-title":"Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study","volume":"16","author":"Li","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"R3-15-20241021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"R4-15-20241021","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/liv.12274","article-title":"Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma","volume":"34","author":"Park","year":"2014","journal-title":"Liver Int"},{"key":"R5-15-20241021","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/hep.26256","article-title":"The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"57","author":"Sieghart","year":"2013","journal-title":"Hepatology"},{"key":"R6-15-20241021","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1007\/s00261-019-02030-2","article-title":"Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: Role in survival prediction and response evaluation","volume":"44","author":"Labeur","year":"2019","journal-title":"Abdom Radiol (NY"},{"key":"R7-15-20241021","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"R8-15-20241021","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.29883","article-title":"Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies","volume":"68","author":"Hyun","year":"2018","journal-title":"Hepatology"},{"key":"R9-15-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000464282","article-title":"Current standard and future perspectives in non-surgical therapy for hepatocellular carcinoma","volume":"96","author":"Eggert","year":"2017","journal-title":"Digestion"},{"key":"R10-15-20241021","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12876-017-0656-z","article-title":"Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: A single center experience","volume":"17","author":"Bettinger","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"R11-15-20241021","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-13-5","article-title":"Prognostic value of \u03b1-fetoprotein and des-\u03b3-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization","volume":"13","author":"Lee","year":"2013","journal-title":"BMC Cancer"},{"key":"R12-15-20241021","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40880-017-0227-2","article-title":"Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: A prognostic nomogram study","volume":"36","author":"He","year":"2017","journal-title":"Chin J Cancer"},{"key":"R13-15-20241021","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12032-016-0827-8","article-title":"Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: A multicenter cohort study with propensity score analysis","volume":"33","author":"Ramaswami","year":"2016","journal-title":"Med Oncol"},{"key":"R14-15-20241021","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.3748\/wjg.v21.i16.4933","article-title":"Prognostic roles of preoperative \u03b1-fetoprotein and des-\u03b3-carboxy prothrombin in hepatocellular carcinoma patients","volume":"21","author":"Meguro","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R15-15-20241021","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MCG.0b013e318182015a","article-title":"Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: A prospective study","volume":"43","author":"Kim","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R16-15-20241021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000381808","article-title":"Tumor markers AFP, AFP-L3, and DCP in hepatocellular carcinoma refractory to transcatheter arterial chemoembolization","volume":"89","author":"Hiraoka","year":"2015","journal-title":"Oncology"},{"key":"R17-15-20241021","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/annonc\/mdw627","article-title":"Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: The Colon Life nomogram","volume":"28","author":"Pietrantonio","year":"2017","journal-title":"Ann Oncol"},{"key":"R18-15-20241021","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-18-3378","article-title":"Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian cancer based on blood biomarkers","volume":"25","author":"Kawakami","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R19-15-20241021","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1158\/1078-0432.CCR-15-2997","article-title":"Rectal cancer: Assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI","volume":"22","author":"Nie","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R20-15-20241021","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: More than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"R21-15-20241021","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2016.72.0748","article-title":"Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer","volume":"35","author":"Fakhry","year":"2017","journal-title":"J Clin Oncol"},{"key":"R22-15-20241021","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jhep.2015.02.034","article-title":"Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization","volume":"63","author":"Xu","year":"2015","journal-title":"J Hepatol"},{"key":"R23-15-20241021","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models: Users' guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"},{"key":"R24-15-20241021","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/bjs.9736","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement","volume":"102","author":"Collins","year":"2015","journal-title":"Br J Surg"},{"key":"R25-15-20241021","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2015.37","article-title":"Decision curve analysis","volume":"313","author":"Fitzgerald","year":"2015","journal-title":"JAMA"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_651_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:43Z","timestamp":1787067463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_651_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_651_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}